Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Novartis AG (NYSE:NVS)

During the Trading Day
85.24 -0.60 / -0.70%
As of 4:02pm ET
Day’s Change
During After-Hours   Switch to standard view »
85.56 +0.3229 / +0.38%
Volume: 17.5K
Health Technology
Pharmaceuticals: Major

Company Description

Novartis AG develops, manufactures, and markets healthcare products. It operates through the following segments: Pharmaceuticals, Alcon, Sandoz, Vaccines & Diagnostics, and Consumer Health. The Pharmaceuticals segment provides patent-protected prescription medicines. The Alcon segment offers surgical, ophthalmic pharmaceuticals, and vision care products. The Sandoz segment provides generic pharmaceuticals. The Vaccines & Diagnostics segment provides human vaccines and blood testing diagnostics. The Consumer Health segment operates two divisions: Over-the-Counter (OTC) and Animal Health. The OTC division develops and sells a wide range of affordable and reliable consumer medications for self-care and numerous common ailments. The Animal Health division's products prolong and improve animals lives. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.

Contact Information

Novartis AG
Lichtstrasse 35
Basel Basel-stadt (basle Town) 4056
P:(161) 324-1111
Investor Relations:
(161) 324-7944



Other institutional4.87%
Mutual fund holders3.85%
Individual stakeholders--

Top Executives

Joseph JimenezChief Executive Officer
Harry KirschChief Financial Officer
Eric CornutChief Ethics, Compliance & Policy Officer
Jürgen Brokatzky-GeigerGlobal Head-Corporate Responsibility
Jeff GeorgeMember-Executive Board